环林D1阴性地幔细胞淋巴瘤.
Chi Young Ok1, L Jeffrey Medeiros1
1Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Human pathology
|November 21, 2024
概括
循环D1阴性地幔细胞淋巴瘤 (MCL) 通常涉及CCND2或CCND3转位,而不是循环D1. 本综述澄清了诊断挑战,并为重新排列的MCL亚型提出了具体的术语.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子病理学分子病理学
背景情况:
- 循环D1阴性地幔细胞淋巴瘤 (MCL) 存在诊断挑战,原因是与典型的MCL无法区分形态和免疫类型.
- 从历史上看,缺乏特定的诊断工具导致了对这种B细胞瘤的混乱.
- 2003年首次通过基因表达造型鉴定发现,环林D1阴性MCL缺乏环林D1过度表达和特征性t(11;14) 转位.
研究的目的:
- 提供循环蛋白D1阴性MCL的时间审查,增强对其演变的理解.
- 讨论目前用于识别和分类这些淋巴瘤的诊断方法.
- 建议改进术语,以提高诊断准确度.
主要方法:
- 审查现有的文献和诊断标准,用于循环素D1阴性MCL.
- 对遗传变化的分析,特别是CCND2和CCND3转位.
- 讨论免疫组织化学和分子诊断技术.
主要成果:
- 大多数循环D1阴性MCL病例表现出涉及CCND2或CCND3与多种基因合作伙伴的转位.
- 形态和免疫类型特征通常与典型的MCL相似,使诊断复杂化.
- 基因表达简介最初确定了这种独特的实体.
结论:
- 当特定的转移已知时,建议使用精细的术语,例如CCND2重新排列的MCL或CCND3重新排列的MCL.
- 术语cyclin D1-negative MCL应该保留在重新排列的基因仍然未被识别的情况下.
- 进一步开发诊断工具对于准确的识别和管理至关重要.
更多相关视频
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
11.4K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
相关概念视频
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Separation of Sister Chromatids
3.6K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.6K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
